Correlation Between Volaris and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both Volaris and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Volaris and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Volaris and Dianthus Therapeutics, you can compare the effects of market volatilities on Volaris and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Volaris with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Volaris and Dianthus Therapeutics.

Diversification Opportunities for Volaris and Dianthus Therapeutics

-0.6

Correlation Coefficient

Volaris  Dianthus Therapeutics

Excellent diversification

The 3 months correlation between Volaris and Dianthus is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Volaris and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and Volaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Volaris are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of Volaris i.e., Volaris and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between Volaris and Dianthus Therapeutics

Given the investment horizon of 90 days Volaris is expected to generate 0.52 times more return on investment than Dianthus Therapeutics. However, Volaris is 1.93 times less risky than Dianthus Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Dianthus Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  623.00  in Volaris on October 9, 2024 and sell it today you would earn a total of  149.00  from holding Volaris or generate 23.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Volaris  vs.  Dianthus Therapeutics

Volaris

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Volaris are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Volaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Volaris and Dianthus Therapeutics

The main advantage of trading using opposite Volaris and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Volaris position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind Volaris and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..